Wipro GE Healthcare to invest over ₹8,000 crore in manufacturing, local R&D over 5 years

Azim Premji, Chairman of Wipro GE Healthcare, highlighted India's growing prowess in the healthcare industry. “With Make in India, we are witnessing an exponential expansion of manufacturing footprint in the country, strengthening India’s capability as the MedTech hub of the world. Wipro GE Healthcare has been committed to this localisation journey for over three decades and this strategic investment is a testament to our vision for this sector,” he said.

Peter J. Arduini, President and CEO of GE HealthCare, underscored India's importance as a high-potential market globally and reiterated the company's dedication to expanding India's domestic capabilities in MedTech manufacturing and R&D.

Chaitanya Sarawate, Managing Director of Wipro GE Healthcare and President & CEO of GE HealthCare South Asia, highlighted the company's focus on innovation and localisation, affirming their bullish outlook on India's potential to emerge as a key player in the global supply chain.

Currently, Wipro GE Healthcare operates four manufacturing plants in Bengaluru, all of which are export-oriented, the company said. The latest plant was established in March 2022 with a little over ₹100 crore worth of investment under the government's Production-Linked Incentive (PLI) scheme.

Wipro GE Healthcare was founded in 1990 as a joint venture between GE Precision Healthcare LLC, USA, and Wipro Enterprises Ltd. Its operations span India, Bangladesh, Sri Lanka, Nepal, the Maldives, and Bhutan.

Also Read: Bharat Biotech initiates TB vaccine clinical trials on adults in India